Addex Therapeutics Ltd
ADXN
$6.07
$0.132.19%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.91M | -4.98M | -4.78M | 9.46M | 7.57M |
| Total Depreciation and Amortization | 7.70K | 32.10K | 91.40K | 215.70K | 216.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.44M | 2.93M | 2.90M | -11.90M | -12.52M |
| Change in Net Operating Assets | 354.80K | 659.10K | 632.10K | -1.98M | -1.32M |
| Cash from Operations | -2.11M | -1.36M | -1.15M | -4.20M | -6.05M |
| Capital Expenditure | -- | 0.00 | -1.50K | -1.50K | -1.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.80K | 57.00K | -23.40K | 5.14M | 5.14M |
| Cash from Investing | 70.80K | 57.00K | -24.90K | 5.14M | 5.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.50K | -5.40K | -5.80K | -8.80K | -73.70K |
| Issuance of Common Stock | 451.50K | 372.10K | 5.90K | 5.90K | 242.40K |
| Repurchase of Common Stock | -9.20K | -2.70K | 0.00 | -22.80K | -27.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.90K | 93.30K | 95.60K | 64.00K | -36.50K |
| Cash from Financing | 655.00K | 558.30K | 106.40K | 42.90K | 122.10K |
| Foreign Exchange rate Adjustments | -21.30K | 19.00K | -17.80K | -16.00K | 113.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 338.20K | -11.60K |
| Net Change in Cash | -1.40M | -725.00K | -1.09M | 1.30M | -686.30K |